Go Back
Head of Pathology
Medical experts discuss current and upcoming treatment strategies to use after CDK4/6 inhibitors in patients with ER+/HER2- advanced breast cancer
Select your medical specialty to receive programmes that matters most to you
The educational programmes hosted on our website are intended for healthcare professionals only.
They are not a substitute for medical professional help, advice, diagnosis or treatment and may not be applicable to every case or country.
Are you a healthcare professional?